Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia
- PMID: 2144918
Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia
Abstract
Plasminogen activator inhibitor activity and antigen were evaluated in plasma, serum and platelet lysate in patients with severe preeclampsia (n = 12), and in normal pregnant women (n = 21). Other parameters, including beta-thromboglobulin and platelet count, were also evaluated. A significant increase (p less than 0.05) in beta-thromboglobulin was observed in platelet poor plasma of preeclamptic women when compared with that of normal pregnant women, and the platelet count was lower in the preeclamptic group than in the normal pregnant group. A significant increase in plasminogen activator inhibitor activity and antigen was observed in platelet poor plasma of the preeclamptic group as compared with normal pregnant women, whereas platelet lysate from preeclamptic women showed a significant decrease in both plasminogen activator inhibitor activity and antigen as compared with that of normal pregnant women. No correlation between beta-thromboglobulin and plasminogen activator inhibitor type 1 antigen in platelet poor plasma was observed, but a significant inverse correlation (r = -0.78, p less than 0.05) between beta-thromboglobulin in platelet poor plasma and plasminogen activator inhibitor-1 antigen in platelet lysate was obtained in preeclamptic patients. However, in platelet poor plasmas obtained from normal platelet rich plasmas activated with thrombin (0.1 IU/ml, 37 degrees C, 1 min), an increase of about 300 ng/ml in beta-thromboglobulin was observed while the increase in plasminogen activator inhibitor was only 4 ng/ml.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.Med Sci Monit. 2008 Nov;14(11):CR574-9. Med Sci Monit. 2008. PMID: 18971874
-
[Endothelial damage and blood coagulation activation in preeclampsia].Minerva Ginecol. 1998 Nov;50(11):463-8. Minerva Ginecol. 1998. PMID: 9882986 Clinical Trial. Italian.
-
Studies on the release of a plasminogen activator inhibitor by human platelets.Thromb Haemost. 1986 Apr 30;55(2):201-5. Thromb Haemost. 1986. PMID: 2940723
-
Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia.Clin Obstet Gynecol. 1992 Jun;35(2):338-50. Clin Obstet Gynecol. 1992. PMID: 1638825 Review.
-
Increased levels of tissue plasminogen activator with a low plasminogen activator inhibitor-1 in a patient with postoperative bleeding.Am J Hematol. 1991 Nov;38(3):226-9. doi: 10.1002/ajh.2830380314. Am J Hematol. 1991. PMID: 1951323 Review.
Cited by
-
Fibrinolytic Changes in Women with Preeclampsia.Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221126172. doi: 10.1177/10760296221126172. Clin Appl Thromb Hemost. 2022. PMID: 36217728 Free PMC article.
-
Decidual-secreted factors alter invasive trophoblast membrane and secreted proteins implying a role for decidual cell regulation of placentation.PLoS One. 2012;7(2):e31418. doi: 10.1371/journal.pone.0031418. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359590 Free PMC article.
-
Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease.Am J Pathol. 1996 Oct;149(4):1229-39. Am J Pathol. 1996. PMID: 8863672 Free PMC article.